Malign Larinks Hastalıkları
Özet
Referanslar
Başaran B. Malign Larinks Hastalıkları. In: Kıroğlu M, Yiğit Ö, Keleş E, Kara CO, Alkan Z (eds.). Kulak Burun Boğaz ve Baş Boyun Cerrahisi Uzmanlık Eğitimi Kaynak Kitap 1. İstanbul: Türk Kulak Burun Boğaz ve Baş Boyun Cerrahisi Derneği; 2018. p. 734–746.
Aydoğan LB. Larinks Kanserleri. In: Önerci TM, Korkmaz MH (eds.). Kulak Burun Boğaz Baş Boyun Cerrahisi – Baş Boyun Cerrahisi. Ankara: Güneş Tıp Kitabevleri; 2021. p. 269–302.
Stenson KM. Epidemiology and risk factors for head and neck cancer. UpToDate. [08 Şubat 2026 tarihinde https://www.uptodate.com/contents/epidemiology- and-risk-factors-for-head-and-neck-cancer adresinden ulaşılmıştır.]
Steuer CE, El-Deiry M, Parks JR, et al. An update on larynx cancer. CA: A Cancer Journal for Clinicians. 2017;67(1):31–50. doi:10.3322/caac.21386
Nocini R, Molteni G, Mattiuzzi C, et al. Updates on larynx cancer epidemiology. Chinese Journal of Cancer Research. 2020;32(1):18–27. doi:10.21147/j.issn.1000-9604.2020.01.03
Wang H, Wei J, Wang B, et al. Role of human papillomavirus in laryngeal squamous cell carcinoma: A meta-analysis of cohort study. Cancer Med. 2020;9(1):204-214. doi:10.1002/cam4.2712
Yang D, Shi Y, Tang Y, et al. Effect of HPV Infection on the Occurrence and Development of Laryngeal Cancer: A Review. J Cancer. 2019;10(19):4455-4462. Published 2019 Jul 23. doi:10.7150/jca.34016
Koch WM, Best S, Stinnett S, Caudell J. Treatment of early (stage I and II) head and neck cancer: The larynx [08 Şubat 2026 tarihinde https://www.uptodate.com/contents/treatment-of-early-stage-i-and-ii-head-and-neck-cancer-the-larynx adresinden ulaşılmıştır.]
Waldfahrer F, Hauptmann B, Iro H. Lymph node metastasis of glottic laryngeal carcinoma. Laryngorhinootologie. 2005;84(2):96–100. doi: 10.1055/s-2004-826075
Esposito ED, Motta S, Cassiano B, et al. Occult lymph node metastases in supraglottic cancers of the larynx. Otolaryngology–Head and Neck Surgery. 2001;124(3):253–257. doi: 10.1067/mhn.2001.113146
Chan Y, Goddard JC (eds.). K.J. Lee’s Essential Otolaryngology: Head & Neck Surgery. 11th ed. New York: McGraw Hill Education; 2016.
American Joint Committee on Cancer. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.
Koch WM, Best S, Stinnett S, Caudell J. Treatment of early (stage I and II) head and neck cancer: The larynx. UpToDate. [15 Şubat 2026 tarihinde https://www.uptodate.com adresinden ulaşıldı.]
Ogol’tsova ES, Paches AI, Matiakin EG, et al. Comparative evaluation of the effectiveness of radiotherapy, surgery and combined treatment of stage I–II laryngeal cancer (T1–2N0M0) based on the data of a cooperative randomized study. Vestnik Otorinolaringologii. 1990; (3): 3–7. PMID: 2200195
Patel KB, Nichols AC, Fung K, et al. Treatment of early stage supraglottic squamous cell carcinoma: meta-analysis comparing primary surgery versus primary radiotherapy. Journal of Otolaryngology – Head & Neck Surgery. 2018;47(1):19. doi:10.1186/s40463-018-0262-2.
Brockstein BE, Stenson KM, Sher DJ, et al. Treatment of locoregionally advanced (stage III and IV) head and neck cancer: The larynx and hypopharynx. UpToDate, 2016.
Burtness B, Harrington KJ, Greil R, et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-048). Lancet. 2019;394:1915–1928.
Ferris RL, Blumenschein G, Fayette J, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck (CheckMate 141). N Engl J Med. 2016;375:1856–1867.
NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers. Version 2024.
Cohen EEW, Soulières D, Le Tourneau C, et al. Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent head and neck squamous cell carcinoma. Lancet. 2019.
Remacle M, Eckel H, Antonelli A, et al. Endoscopic cordectomy: a proposal for a classification by the Working Committee, European Laryngological Society. European Archives of Oto-Rhino-Laryngology. 2000;257(4):227–231. doi:10.1007/s004050050228
Marrero-Gonzalez AR, Diemer TJ, Nguyen SA, et al. Application of artificial intelligence in laryngeal lesions: a systematic review and meta-analysis. European Archives of Oto-Rhino-Laryngology. 2025;282(4):1543–1555. doi:10.1007/s00405-024-09075-0
